Market revenue in 2023 | USD 266.3 million |
Market revenue in 2030 | USD 369.8 million |
Growth rate | 4.8% (CAGR from 2023 to 2030) |
Largest segment | Infectious diseases |
Fastest growing segment | Oncology |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oncology, Prenatal Testing, Endocrinology, Other Applications, Hematology, Infectious Diseases |
Key market players worldwide | Roche, Abbott Laboratories, Qiagen NV, Bayer AG, Nova Biomedical, Danaher Corp, Nipro Corp, Bio-Rad Laboratories Inc, Agilent Technologies Inc, BioMerieux SA, OraSure Technologies Inc, Abaxis |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to point-of-care molecular diagnostics market will help companies and investors design strategic landscapes.
Infectious diseases was the largest segment with a revenue share of 93.58% in 2023. Horizon Databook has segmented the Germany point-of-care molecular diagnostics market based on oncology, prenatal testing, endocrinology, other applications, hematology, infectious diseases covering the revenue growth of each sub-segment from 2018 to 2030.
Germany holds a considerable share of Europe’s point-of-care molecular diagnostics market, owing primarily to its large geriatric population. According to the UN’s population data, one in every 20 people in Germany is over 80 years, which is expected to increase to one in every six individuals by 2050.
Problems with the increasing geriatric population include a higher risk of chronic diseases, such as cardiovascular diseases, diabetes, and neurovascular disorders, due to the onset of senescence & decreased immunity levels.
Rapid diagnostic techniques such as point-of-care molecular diagnostic devices are useful for this demographic. Key manufacturer such as Roche is strengthening its operations in Germany, which is expected to boost the point-of-care molecular diagnostics market.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany point-of-care molecular diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Germany point-of-care molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account